反应详情

The title compounds were prepared according to the procedure for Example 102 using diethyl(4-{[4-chloro-5-(trifluoromethyl)pyrimidin-2-yl]amino}-3-methoxybenzyl)phosphonate and 4-[4-(4-acetyl piperazin-1-yl)cyclohexyl]-7-amino-2-methyl-2,3-dihydro-1H-isoindol-1-one (Compound 237A). The reaction mixture was purified by MDP. Example 237 was first peak to elute. 1H NMR (CDCl3, 400 MHz): δ=1.28 (t, J=6.95 Hz, 6H), 1.50-1.73 (m, 7H), 2.02 (s, 2H), 2.12 (s, 3H), 2.50 (br. s., 2H), 2.62 (br. s., 3H), 3.13-3.21 (m, 2H), 3.22 (s, 3H), 3.42-3.75 (m, 4H), 3.93 (s, 3H), 3.99-4.10 (m, 4H), 4.38 (s, 2H), 6.90 (dt, J=8.08, 2.15 Hz, 1H), 6.94 (t, J=2.02 Hz, 1H), 7.34 (d, J=8.84 Hz, 1H), 7.63 (s, 1H), 8.28 (d, J=7.58 Hz, 1H), 8.40 (s, 1H), 8.64 (d, J=8.59 Hz, 1H), 10.51 (s, 1H). MS (ES+): m/z 788.31 [MH+] (TOF, polar). Example 238 eluted afterwards: 1H NMR (CDCl3, 400 MHz): δ=1.28 (t, J=7.07 Hz, 6H), 1.87 (d, J=4.04 Hz, 2H), 1.91-2.03 (m, 2H), 2.12-2.25 (m, 7H), 2.84 (br. s., 2H), 3.21 (s, 3H), 3.23-3.33 (m, 4H), 3.86 (s, 3H), 3.93 (br. s., 2H), 4.04 (qdd, J=7.31, 7.31, 7.31, 7.14, 1.77 Hz, 4H), 4.38 (s, 2H), 6.94-7.00 (m, 2H), 7.36 (d, J=7.83 Hz, 1H), 7.71 (br. s., 1H), 8.23 (br. s., 2H), 11.20 (br. s., 1H). MS (ES+): m/z 788.31 [MH+] (TOF, polar).

1. customThe reaction mixture was purified by MDP
2. washto elute
3. washExample 238 eluted afterwards